The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Prestige Brands Holdings Inc

NYSE: PBH
Last

(U.S.) $53.97

Today's change-0.69 -1.26%
Updated May 31 2:24 PM EDT. Delayed by at least 15 minutes.
 

Prestige Brands Holdings Inc

NYSE: PBH
Last

(U.S.) $53.97

Today's change-0.69 -1.26%
Updated May 31 2:24 PM EDT. Delayed by at least 15 minutes.

Prestige Brands Holdings Inc down (U.S.)$0.69

Prestige Brands Holdings Inc is lower today, dropping (U.S.)$0.69 or 1.26% to (U.S.)$53.97. Shares have lost 1.94% over the last five days, but have gained 4.84% over the last year to date. This security has outperformed the S&P 500 by 23.67% during the last year.

Key company metrics

  • Open(U.S.) $54.70
  • Previous close(U.S.) $54.66
  • High(U.S.) $55.00
  • Low(U.S.) $53.66
  • Bid / Ask(U.S.) $53.94 / (U.S.) $53.97
  • YTD % change+4.84%
  • Volume236,106
  • Average volume (10-day)446,299
  • Average volume (1-month)497,317
  • Average volume (3-month)562,186
  • 52-week range(U.S.) $42.41 to (U.S.) $58.09
  • Beta1.71
  • Trailing P/E28.70×
  • P/E 1 year forward23.26×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.88
Updated May 31 2:24 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.39%

Based on its net profit margin of 12.39%, Prestige Brands Holdings Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.13%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue208200206192
Total other revenue--------
Total revenue208200206192
Gross profit118117120112
Total cost of revenue90838680
Total operating expense160138136130
Selling / general / administrative47484444
Research & development--------
Depreciation / amortization6666
Interest expense (income), net operating--------
Unusual expense (income)18000
Other operating expenses, total--------
Operating income48637062
Interest income (expense), net non-operating-23-19-21-22
Gain (loss) on sale of assets00----
Other--------
Income before tax25434940
Income after tax14283226
Income tax, total11151714
Net income14283226
Total adjustments to net income--------
Net income before extra. items14283226
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items14283226
Inc. avail. to common incl. extra. items14283226
Diluted net income14283226
Dilution adjustment0------
Diluted weighted average shares53535353
Diluted EPS excluding extraordinary itemsvalue per share0.260.530.600.49
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.450.530.600.50
R